European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
New DG Iweala Calls On WTO To ‘Walk & Chew’ Gum – Talk With Pharma About Expanding COVID Vaccine Supplies While Talks Continue On ‘IP ‘Waiver’ 01/03/2021 Elaine Ruth Fletcher Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May. […] Continue reading -> Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
Proposed IP Waiver On COVID Vaccines & Medicines Gets Burst Of Public Support – But ‘Third Way’ Approach By WTO More Likely 26/02/2021 Kerry Cullinan & Elaine Ruth Fletcher Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading -> Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts
Israel Produces Best Evidence Yet About Pfizer Vaccine – But Netanyahu’s Vaccine Politics & Airport Chaos Cast Shadow Over Success 25/02/2021 Elaine Ruth Fletcher The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading -> Posts navigation Older postsNewer posts